Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression.
Kosalaraksa P, Bunupuradah T, Vonthanak S, Wiangnon S, Hansudewechakul R, Vibol U, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Lumbiganon P, Sopa B, Apornpong T, Chuenyam T, Cooper DA, Ruxrungtham K, Ananworanich J, Puthanakit T. Kosalaraksa P, et al. Among authors: ruxrungtham k. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1679-86. doi: 10.1089/AID.2011.0373. Epub 2012 Jul 25. AIDS Res Hum Retroviruses. 2012. PMID: 22734817 Free PMC article.
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.
Kroon ED, Ungsedhapand C, Ruxrungtham K, Chuenyam M, Ubolyam S, Newell ME, van Leeuwen R, Kunanusont C, Buranapraditkul S, Sirivichayakul S, Lange JM, Cooper DA, Phanuphak P. Kroon ED, et al. Among authors: ruxrungtham k. AIDS. 2000 Jul 7;14(10):1349-56. doi: 10.1097/00002030-200007070-00007. AIDS. 2000. PMID: 10930149 Clinical Trial.
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients.
Ungsedhapand C, Kroon ED, Suwanagool S, Ruxrungtham K, Yimsuan N, Sonjai A, Ubolyam S, Buranapraditkun S, Tiengrim S, Pakker N, Kunanusont C, Lange JM, Cooper DA, Phanuphak P. Ungsedhapand C, et al. Among authors: ruxrungtham k. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):116-23. doi: 10.1097/00126334-200106010-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11404532 Clinical Trial.
Dose-escalating study of the safety and pharmacokinetics of nelfinavir in HIV-exposed neonates.
Rongkavilit C, van Heeswijk RP, Limpongsanurak S, Thaithumyanon P, Boonrod C, Hassink EA, Srigritsanapol A, Chuenyam T, Ubolyam S, Hoetelmans RM, Ruxrungtham K, Lange JM, Cooper DA, Phanuphak P. Rongkavilit C, et al. Among authors: ruxrungtham k. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):455-63. doi: 10.1097/00042560-200204150-00005. J Acquir Immune Defic Syndr. 2002. PMID: 11981361 Clinical Trial.
Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.
Cardiello PG, Monhaphol T, Mahanontharit A, van Heeswijk RP, Burger D, Hill A, Ruxrungtham K, Lange JM, Cooper DA, Phanuphak P. Cardiello PG, et al. Among authors: ruxrungtham k. J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):375-9. doi: 10.1097/00126334-200304010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12640194 Clinical Trial.
392 results